Hinge Health Inc. Class A Common Stock vs Snowflake Inc — how do they compare? Hinge Health Inc. Class A Common Stock trades at $103.99 (market cap $8.47B), while Snowflake Inc trades at $327.09 (market cap $118.22B). The key difference: Snowflake Inc is far larger — about 14× Hinge Health Inc. Class A Common Stock's market cap, and Hinge Health Inc. Class A Common Stock is trading nearer its 52-week high, Snowflake Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Hinge Health Inc. Class A Common Stock for 0 Days and Snowflake Inc for 53 Days on average.
| HNGE | SNOW | |
|---|---|---|
Market Cap | $8.47B | $118.22B |
Volume | 1,624,526 | 4,578,402 |
Sector | Health | Technology |
52-Week High | $105.14 | $368.89 |
52-Week Low | $31.17 | $121.11 |
Typical Hold Time | 0 Days | 53 Days |
Enterprise Value | $8.09B | $118.64B |
Signals from Pluang's Aura AI — not financial advice
Hinge Health (HNGE) trades at $105.14, up 0.31% on the day and near its 52-week high. The stock shows strong analyst support with a 93.75% buy rating, though the current price exceeds the consensus target of $101.62. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results due November 2. Fundamentals indicate robust revenue growth projections from $588 million in 2025 to $720 million in 2026, alongside a shift to profitability, but valuation multiples like EV/EBITDA at 82.33 remain elevated.
The outlook is cautiously optimistic given projected profitability and expansion into migraine and GI care, but risks include high insider selling, competitive pressures, and the stock's premium valuation. Execution on growth targets and Q3 earnings will be critical for sustaining momentum.
Snowflake (SNOW) trades at $357.76, down 0.72% today, with strong technical momentum showing bullish moving averages and support at $355. The company demonstrates robust revenue growth, reaching $3.63 billion in 2025, though it remains unprofitable with a -20.07% net margin. Recent earnings have consistently beaten expectations, and analyst sentiment is overwhelmingly positive with 81% buy ratings and a $418.03 consensus target.
The outlook remains constructive given strong revenue growth and strategic partnerships, but investors face risks from continued losses, high valuation multiples (P/S 22.66), and potential dilution from the recent $3.75 billion convertible note offering. The stock offers growth exposure but requires tolerance for current profitability challenges.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Hinge Health Inc. operates a digital musculoskeletal (MSK) care platform that delivers exercise therapy for joint and muscle conditions through health plans and employers. Its Precision Motion Technology combines wearable sensors and computer vision to guide patients through clinician-directed physical therapy remotely.
Read more on HNGE →Founded in 2012, Snowflake is a data lake, warehousing, and sharing company that came public in 2020. To date, the company has over 3,000 customers including nearly 30% of the Fortune 500 as its customers. Snowflake's data lake stores unstructured and semistructured data that can then be used in analytics to create insights stored in its data warehouse. Snowflake's data sharing capability allows enterprises to easily buy and ingest data almost instantaneously compared with a traditionally months-long process. Overall, the company is known for the fact that all of its data solutions that can be hosted on various public clouds.
Read more on SNOW →